Picture of AtriCure logo

ATRC AtriCure News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

AtriCure Inc reports results for the quarter ended in September - Earnings Summary

* AtriCure Inc  ATRC.OQ  reported a quarterly adjusted loss
of 27
cents​​ per share for the quarter ended in September. The mean
expectation of seven analysts for the quarter was for a loss
of 25 cents per share.
    * Revenue rose 18.1% to $83.25 million from a year ago;
analysts
expected $81.33 million. 
    * AtriCure Inc's reported EPS for the quarter was a loss
of 27
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * AtriCure Inc shares had risen by 7.7% this quarter and
lost 39.4% so far this year.
    * The company reported a quarterly loss of $12.27 million.
    * Wall Street's median 12-month price target for AtriCure
Inc is
$65.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
1 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.25          -0.27          Missed
 Jun. 30 2022      -0.29          -0.32          Missed
 Mar. 31 2022      -0.32          -0.33          Missed
 Dec. 31 2021      -0.29          -0.30          Missed

Recent news on AtriCure

See all news